Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial

Jenkin D., Ritchie AJ., Aboagye J., Fedosyuk S., Thorley L., Provstgaad-Morys S., Sanders H., Bellamy D., Makinson R., Xiang ZQ., Bolam E., Tarrant R., Ramos Lopez F., Platt A., Poulton I., Green C., Ertl HCJ., Ewer KJ., Douglas AD.

DOI

10.1016/s2666-5247(22)00126-4

Type

Journal article

Journal

The Lancet Microbe

Publisher

Elsevier BV

Publication Date

09/2022

Volume

3

Pages

e663 - e671

Permalink Original publication